Ginsenoside Rb1: The new treatment measure of myasthenia gravis.
Chen W, Meng QF, Sui JK, Wang YJ, Li XL, Liu S, Li H, Wang CC, Li CH, Li YB.
Chen W, et al. Among authors: li xl, li h, li ch, li yb.
Int Immunopharmacol. 2016 Dec;41:136-143. doi: 10.1016/j.intimp.2016.08.028. Epub 2016 Sep 3.
Int Immunopharmacol. 2016.
PMID: 27601384